» Authors » Robert Kronstrand

Robert Kronstrand

Explore the profile of Robert Kronstrand including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 104
Citations 1000
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gomonit M, Roman M, Skillman B, Truver M, Kronstrand R
J Anal Toxicol . 2025 Mar; PMID: 40085069
Phosphatidylethanol (PEth) consists of phospholipids synthesized in erythrocyte cell membranes in the presence of ethanol and serves as a sensitive and specific indicator of alcohol consumption. Further research on PEth...
2.
Axelsson M, Lovgren H, Kronstrand R, Green H, Bergstrom M
Basic Clin Pharmacol Toxicol . 2025 Jan; 136(2):e14117. PMID: 39806572
New psychoactive substances (NPS) are health-hazardous through unpredictable toxicity and effects and largely unknown epidemiology, motivating studies of the latter. Up to 138 NPS were retrospectively identified using liquid chromatography-high...
3.
Persson M, Kronstrand R, Evans-Brown M, Green H
Drug Test Anal . 2024 Jun; PMID: 38894658
Semi-synthetic cannabinoids (SSCs) including hexahydrocannabinol (HHC) are emerging on the drug market and sold openly as purportedly legal replacements for cannabis and Δ-THC. By the beginning of 2024, 24 European...
4.
Lennborn U, Johansson A, Lindgren E, Nielsen E, Sandler H, Bertilsson M, et al.
Ups J Med Sci . 2024 Jun; 129. PMID: 38863729
Background: Standard dosages of analgesic and sedative drugs are given to intensive care patients. The resulting range of blood concentrations and corresponding clinical responses need to be better examined. The...
5.
Lindbom K, Norman C, Baginski S, Krebs L, Stalberga D, Rautio T, et al.
Drug Test Anal . 2024 May; PMID: 38804224
Hexahydrocannabinol (HHC), hexahydrocannabiphorol (HHCP) and their acetates, HHC-O and HHCP-O, respectively, are emerging in Europe as alternatives to tetrahydrocannabinol (THC). This study aimed to elucidate the metabolic pathways of the...
6.
Taoussi O, Berardinelli D, Zaami S, Tavoletta F, Basile G, Kronstrand R, et al.
Arch Toxicol . 2024 Apr; 98(7):2101-2116. PMID: 38582802
Following isotonitazene scheduling in 2019, the availability of alternative 2-benzylbenzimidazole opioids (nitazenes) on the global drug market increased, resulting in many fatalities worldwide. Nitazenes are potent µ-opioid receptor agonists with...
7.
Kronstrand R, Roman M, Green H, Truver M
J Anal Toxicol . 2024 Apr; 48(4):235-241. PMID: 38581662
Hexahydrocannabinol (HHC) was first reported in the EU in May 2022. HHC has three chiral carbon atoms, but only (6aR,9R,10aR)-HHC (9R-HHC) and (6aR,9S,10aR)-HHC (9S-HHC) have been encountered in HHC products....
8.
Persson M, Vikingsson S, Kronstrand R, Green H
Drug Test Anal . 2023 Jul; 16(4):339-347. PMID: 37489044
Many new psychoactive substances (NPS) are stimulants, and information about their potency and abuse potential is often lacking. To start addressing this need, a method measuring the inhibition of the...
9.
Kronstrand R, Roman M, Johansson A, Wu X, Green H, Truver M
J Anal Toxicol . 2023 Jun; 47(7):640-643. PMID: 37348041
Rilmazafone is a pro-drug that can be prescribed in Japan to treat insomnia. Rilmazafone metabolizes into active compounds by a ring closure resulting in a triazolo benzodiazepine structure similar to...
10.
Favretto D, Cooper G, Andraus M, Sporkert F, Agius R, Appenzeller B, et al.
Drug Test Anal . 2023 Jun; 15(9):1042-1046. PMID: 37332075
No abstract available.